Literature DB >> 7927698

Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.

P H Jakobsen1, V McKay, S D Morris-Jones, W McGuire, M B van Hensbroek, S Meisner, K Bendtzen, I Schousboe, I C Bygbjerg, B M Greenwood.   

Abstract

To investigate the pathogenic versus the protective role of cytokines and toxin-binding factors in Plasmodium falciparum infections, we measured the concentrations of tumor necrosis factor alpha, interleukin-1 alpha (IL-1 alpha), IL-1 beta, IL-1 receptor antagonist, and IL-6, as well as soluble receptors of tumor necrosis factor and IL-6 (sIL-6R) in serum of Gambian children with cerebral malaria, mild or asymptomatic malaria, or other illnesses unrelated to malaria. Because cytokine secretion may be triggered by toxic structures containing phosphatidylinositol (PI), we also measured concentrations of anti-PI antibodies and the PI-binding serum protein beta-2-glycoprotein I. We found increased concentrations of IL-6, sIL-6R, IL-1ra, and some immunoglobulin M antibodies against PI in children with cerebral malaria, but those who died had decreased concentrations of beta-2-glycoprotein I. We conclude that increased concentrations of cytokines and soluble cytokine receptors represent a normal host response to P. falciparum infections but that excessive secretion of cytokines like IL-6 may predispose to cerebral malaria and a fatal outcome while beta-2-glycoprotein I may protect against a fatal outcome of cerebral malaria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927698      PMCID: PMC303119          DOI: 10.1128/iai.62.10.4374-4379.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria.

Authors:  G E Grau; P F Piguet; H D Engers; J A Louis; P Vassalli; P H Lambert
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

2.  Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of beta 2-glycoprotein I and its subfractions.

Authors:  I Schousboe
Journal:  J Biochem Biophys Methods       Date:  1982-06

3.  Anti-interleukin-6 antibodies in normal human serum.

Authors:  M B Hansen; M Svenson; M Diamant; K Bendtzen
Journal:  Scand J Immunol       Date:  1991-06       Impact factor: 3.487

4.  Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria.

Authors:  P Kern; C J Hemmer; J Van Damme; H J Gruss; M Dietrich
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

5.  Human anti-interleukin 1 alpha antibodies.

Authors:  M B Hansen; M Svenson; K Bendtzen
Journal:  Immunol Lett       Date:  1991-09       Impact factor: 3.685

6.  Phase I study of recombinant tumor necrosis factor in cancer patients.

Authors:  M Blick; S A Sherwin; M Rosenblum; J Gutterman
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

7.  The role of T lymphocytes in immunity to Plasmodium falciparum. Enhancement of neutrophil-mediated parasite killing by lymphotoxin and IFN-gamma: comparisons with tumor necrosis factor effects.

Authors:  L M Kumaratilake; A Ferrante; C Rzepczyk
Journal:  J Immunol       Date:  1991-01-15       Impact factor: 5.422

8.  Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children.

Authors:  M E Molyneux; T E Taylor; J J Wirima; A Borgstein
Journal:  Q J Med       Date:  1989-05

9.  TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

Authors:  D Kwiatkowski; A V Hill; I Sambou; P Twumasi; J Castracane; K R Manogue; A Cerami; D R Brewster; B M Greenwood
Journal:  Lancet       Date:  1990-11-17       Impact factor: 79.321

10.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.

Authors:  L Schofield; F Hackett
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.

Authors:  John M Ong'echa; Gregory C Davenport; John M Vulule; James B Hittner; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

3.  N-acetylcysteine in severe falciparum malaria in Thailand.

Authors:  Sombat Treeprasertsuk; Srivicha Krudsood; Thanawat Tosukhowong; Wirach Maek-A-Nantawat; Suparp Vannaphan; Tosaporn Saengnetswang; Sornchai Looareesuwan; Walter F Kuhn; Gary Brittenham; James Carroll
Journal:  Southeast Asian J Trop Med Public Health       Date:  2003-03       Impact factor: 0.267

4.  Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.

Authors:  Chandy C John; Gregory S Park; Nadia Sam-Agudu; Robert O Opoka; Michael J Boivin
Journal:  Cytokine       Date:  2008-02-20       Impact factor: 3.861

5.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

6.  Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.

Authors:  Leanne J Robinson; Marthe C D'Ombrain; Danielle I Stanisic; Jack Taraika; Nicholas Bernard; Jack S Richards; James G Beeson; Livingstone Tavul; Pascal Michon; Ivo Mueller; Louis Schofield
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

Review 7.  HIV and co-infections.

Authors:  Christina C Chang; Megan Crane; Jingling Zhou; Michael Mina; Jeffrey J Post; Barbara A Cameron; Andrew R Lloyd; Anthony Jaworowski; Martyn A French; Sharon R Lewin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

8.  A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand.

Authors:  Jun Ohashi; Izumi Naka; Akihiro Doi; Jintana Patarapotikul; Hathairad Hananantachai; Noppadon Tangpukdee; Sornchai Looareesuwan; Katsushi Tokunaga
Journal:  Malar J       Date:  2005-08-14       Impact factor: 2.979

9.  Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.

Authors:  Nana O Wilson; Wesley Solomon; Leonard Anderson; John Patrickson; Sidney Pitts; Vincent Bond; Mingli Liu; Jonathan K Stiles
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India.

Authors:  Vidhan Jain; Henry B Armah; Jon E Tongren; Renée M Ned; Nana O Wilson; Sara Crawford; Pradeep K Joel; Mrigendra P Singh; Avinash C Nagpal; A P Dash; Venkatachalam Udhayakumar; Neeru Singh; Jonathan K Stiles
Journal:  Malar J       Date:  2008-05-19       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.